Literature DB >> 19921167

Stone composition and metabolic status.

B S Bibilash1, Adarsh Vijay, Y M Fazil Marickar.   

Abstract

This paper aims to study the correlation between biochemical risk factors of the stone former and the type of oxalate stone formed, namely calcium oxalate monohydrate (COM) and calcium oxalate dehydrate (COD). A retrospective study of 487 patients who had been attending the urinary stone clinic, Trivandrum during 1998-2007 was conducted. The stones retrieved from them were subjected to chemical analysis and FTIR spectrographic analysis. They were categorized into COM, COD, mixed COM+COD and others. Of 142 pure calcium oxalate stone patients, 87 were predominantly COM stone formers and 55 COD stone formers. Their metabolic status of 24 h urine and serum was assessed. The values of urine calcium, phosphorus, uric acid, magnesium, creatinine, oxalate, citric acid, sodium and potassium, serum values of calcium, phosphorus, uric acid, magnesium and creatinine and calculated values of creatinine clearance, tubular reabsorption of phosphate, calcium magnesium ratio and calcium oxalate ratio were recorded. Comparison was made between the COM stone group and the COD stone group. Patients forming COM stones had significantly higher mean values for urine calcium (P < 0.05), oxalate (P < 0.01) and magnesium (P < 0.05) levels and significantly lower level of urine calcium-oxalate ratio (P < 0.01) and urine calcium-magnesium ratio (P < 0.01) compared to COD stone forming patients. All other values failed to show significant difference. Patients, with higher urine oxalate, formed COM stones. Those with low magnesium (which is an inhibitor) formed more of COD stones. Urine calcium was high in both groups without showing significant variation from the mean. In patients with high calcium-oxalate and calcium-magnesium ratios, there is higher chance of forming a COD stone than COM. Identification of the crystallization pattern of the calcium stone will help in selecting treatment modalities.

Entities:  

Mesh:

Year:  2009        PMID: 19921167     DOI: 10.1007/s00240-009-0229-x

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  21 in total

1.  Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.

Authors:  E Takasaki
Journal:  Invest Urol       Date:  1975-01

2.  Calcium stone disease: a multiform reality.

Authors:  Alberto Trinchieri; Chiara Castelnuovo; Renata Lizzano; Giampaolo Zanetti
Journal:  Urol Res       Date:  2005-06

3.  Magnesium therapy for recurring calcium oxalate urinary calculi.

Authors:  I Melnick; R R Landes; A A Hoffman; J F Burch
Journal:  J Urol       Date:  1971-01       Impact factor: 7.450

4.  Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.

Authors:  P O Schwille; A Schmiedl; U Herrmann; J Fan; D Gottlieb; M Manoharan; J Wipplinger
Journal:  Urol Res       Date:  1999-04

5.  Oral magnesium intake and its effect on various urinary constituents in the prophylaxis of urolithiasis.

Authors:  F P Kohler; C A Uhle
Journal:  J Urol       Date:  1966-11       Impact factor: 7.450

Review 6.  Magnesium therapy for nephrolithiasis.

Authors:  L Massey
Journal:  Magnes Res       Date:  2005-06       Impact factor: 1.115

7.  Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.

Authors:  A Cupisti; E Morelli; S Lupetti; M Meola; G Barsotti
Journal:  Nephron       Date:  1992       Impact factor: 2.847

8.  Aspects of the influence of magnesium ions on the formation of calcium oxalate.

Authors:  W Wunderlich
Journal:  Urol Res       Date:  1981

9.  Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.

Authors:  C D Fetner; D E Barilla; J Townsend; C Y Pak
Journal:  J Urol       Date:  1978-10       Impact factor: 7.450

10.  Effects of magnesium on calcium oxalate crystallization.

Authors:  M K Li; N J Blacklock; J Garside
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450

View more
  5 in total

1.  Characterization of kidney stones using thermogravimetric analysis with electron dispersive spectroscopy.

Authors:  Heow Pueh Lee; Dalun Leong; Chin Tiong Heng
Journal:  Urol Res       Date:  2011-10-04

2.  A huge bladder calcium oxalate stone.

Authors:  Peng Xia; Jifu Zhang; Wenwei Chen
Journal:  Urolithiasis       Date:  2014-10-14       Impact factor: 3.436

3.  An update on metabolic assessment in patients with urinary lithiasis.

Authors:  Carmen Regina Petean Ruiz Amaro; Jose Goldberg; Patricia Capuzzo Damasio; Victor Augusto Leitão; Benjamin Turney; Carlos Roberto Padovani; João Luiz Amaro
Journal:  World J Urol       Date:  2014-03-13       Impact factor: 4.226

4.  Oxalate Activates Autophagy to Induce Ferroptosis of Renal Tubular Epithelial Cells and Participates in the Formation of Kidney Stones.

Authors:  Qianlin Song; Wenbiao Liao; Xin Chen; Ziqi He; Bin Li; Junwei Liu; Lang Liu; Yunhe Xiong; Chao Song; Sixing Yang
Journal:  Oxid Med Cell Longev       Date:  2021-10-06       Impact factor: 6.543

5.  Extraction of giant bladder calcium oxalate stone: A case report.

Authors:  Navin Shrestha; Le Zhou; Chun Huan Hu
Journal:  Int J Surg Case Rep       Date:  2020-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.